BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21576832)

  • 1. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.
    Arase Y; Suzuki F; Kobayashi M; Suzuki Y; Kawamura Y; Matsumoto N; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Ohmoto Y; Amakawa K; Tsuji H; Hsieh SD; Kato K; Tanabe M; Ogawa K; Hara S; Kobayashi T
    Intern Med; 2011; 50(10):1081-7. PubMed ID: 21576832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.
    Arase Y; Suzuki F; Ikeda K; Kumada H; Tsuji H; Kobayashi T
    J Gastroenterol; 2009; 44(10):1064-70. PubMed ID: 19533014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease.
    Seko Y; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Mizuno N; Takemura M; Taketani H; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Okanoue T; Itoh Y
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study.
    Shibata M; Sato KK; Uehara S; Koh H; Oue K; Kambe H; Morimoto M; Hayashi T
    J Epidemiol; 2020 Apr; 30(4):163-169. PubMed ID: 30930374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease.
    Tanaka M; Mori K; Takahashi S; Higashiura Y; Ohnishi H; Hanawa N; Furuhashi M
    Nephrol Dial Transplant; 2023 Feb; 38(3):700-711. PubMed ID: 35612975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.
    Targher G; Mantovani A; Pichiri I; Mingolla L; Cavalieri V; Mantovani W; Pancheri S; Trombetta M; Zoppini G; Chonchol M; Byrne CD; Bonora E
    Diabetes Care; 2014 Jun; 37(6):1729-36. PubMed ID: 24696459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.
    Kawamura Y; Arase Y; Ikeda K; Seko Y; Imai N; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ohmoto Y; Amakawa K; Tsuji H; Kumada H
    Am J Gastroenterol; 2012 Feb; 107(2):253-61. PubMed ID: 22008893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.
    Chang Y; Ryu S; Sung E; Woo HY; Oh E; Cha K; Jung E; Kim WS
    Metabolism; 2008 Apr; 57(4):569-76. PubMed ID: 18328362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H; Dawwas GK; Liu X; Nguyen MH
    J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.
    Miyakoshi T; Nakasone Y; Sato Y; Yamauchi K; Hashikura R; Takayama M; Hirabayashi K; Koike H; Moriya T; Aizawa T
    Nephrology (Carlton); 2017 Sep; 22(9):684-689. PubMed ID: 27282755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cigarette smoking on new-onset of chronic kidney disease in a Japanese population without prior chronic kidney disease: Iki epidemiological study of atherosclerosis and chronic kidney disease (ISSA-CKD).
    Ito K; Maeda T; Tada K; Takahashi K; Yasuno T; Masutani K; Mukoubara S; Arima H; Nakashima H
    Clin Exp Nephrol; 2020 Oct; 24(10):919-926. PubMed ID: 32577942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    Huh JH; Kim JY; Choi E; Kim JS; Chang Y; Sung KC
    PLoS One; 2017; 12(7):e0180951. PubMed ID: 28738057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD).
    Roderburg C; Krieg S; Krieg A; Demir M; Luedde T; Kostev K; Loosen SH
    Eur J Med Res; 2023 Apr; 28(1):153. PubMed ID: 37062837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study.
    Kanno A; Kikuya M; Ohkubo T; Hashimoto T; Satoh M; Hirose T; Obara T; Metoki H; Inoue R; Asayama K; Shishido Y; Hoshi H; Nakayama M; Totsune K; Satoh H; Sato H; Imai Y
    Nephrol Dial Transplant; 2012 Aug; 27(8):3218-23. PubMed ID: 22510379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
    Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
    Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and risk factors of chronic kidney disease in community-based patients with diabetes].
    Lin HB; Chen Y; Shen P; Li XY; Si YQ; Zhang DD; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):416-421. PubMed ID: 29930407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.